2017 年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读

2017-01-30 中国医学前沿杂志(电子版).2017,9(1):37-47.

2017 年全球慢性阻塞性肺疾病防治创议(Global Initiative for Chronic Obstructive Lung Disease,GOLD)报告于2016 年11 月16 日世界慢阻肺日发布,对于慢阻肺的定义、发病机制、评估、个体化治疗、急性加重及合并症等方面均进行了全面修改,其中的一些内容尚需在临床上进一步验证。本文对其重要更新内容进行简介和解读。

中文标题:

2017 年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读

发布机构:

发布日期:

2017-01-30

简要介绍:

2017 年全球慢性阻塞性肺疾病防治创议(Global Initiative for Chronic Obstructive Lung Disease,GOLD)报告于2016 年11 月16 日世界慢阻肺日发布,对于慢阻肺的定义、发病机制、评估、个体化治疗、急性加重及合并症等方面均进行了全面修改,其中的一些内容尚需在临床上进一步验证。本文对其重要更新内容进行简介和解读。北京大学第三医院呼吸与危重症医学科 陈亚红

拓展指南:肺部疾病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读)] GetToolGuiderByIdResponse(projectId=1, id=824c71c00138ea4f, title=2017 年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读, enTitle=, guiderFrom=中国医学前沿杂志(电子版).2017,9(1):37-47., authorId=null, author=, summary=2017 年全球慢性阻塞性肺疾病防治创议(Global Initiative for Chronic Obstructive Lung Disease,GOLD)报告于2016 年11 月16 日世界慢阻肺日发布,对于慢阻肺的定义、发病机制、评估、个体化治疗、急性加重及合并症等方面均进行了全面修改,其中的一些内容尚需在临床上进一步验证。本文对其重要更新内容进行简介和解读。, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Jan 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=2017 年全球慢性阻塞性肺疾病防治创议(Global Initiative for Chronic Obstructive Lung Disease,GOLD)报告于2016 年11 月16 日世界慢阻肺日发布,对于慢阻肺的定义、发病机制、评估、个体化治疗、急性加重及合并症等方面均进行了全面修改,其中的一些内容尚需在临床上进一步验证。本文对其重要更新内容进行简介和解读。北京大学第三医院呼吸与危重症医学科 陈亚红 <div> </div> 拓展指南:<strong>与<font color="red">肺部疾病</font>相关指南:</strong><br> <ul> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ed5191c00135ae39" title="慢性阻塞性肺疾病防治全球倡议2016解读" target="_blank" style="font-size: 9pt;">慢性阻塞性肺疾病防治全球倡议2016解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9bfcb1c0013a90d8" title="慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读" target="_blank">慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=e24731c0013315f2" title="2017 GOLD慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略" target="_blank">2017 GOLD慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=05fcc1c00123866d" title="2013 慢性阻塞性肺疾病诊治指南(2013年修订版)" target="_blank">2013 慢性阻塞性肺疾病诊治指南(2013年修订版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%82%BA%E7%96%BE%E7%97%85" target="_blank">有关肺疾病更多指南</a></ul>, tagList=[TagDto(tagId=2115, tagName=慢性阻塞性肺疾病), TagDto(tagId=757, tagName=诊断), TagDto(tagId=65, tagName=治疗), TagDto(tagId=2246, tagName=预防)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3495, appHits=386, showAppHits=11, pcHits=1854, showPcHits=1520, likes=118, shares=17, comments=4, approvalStatus=1, publishedTime=Wed Mar 08 14:33:39 CST 2017, publishedTimeString=2017-01-30, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Wed Mar 08 14:33:39 CST 2017, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 20:59:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读)])
2017 年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1182233, encodeId=6343118223372, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90426454317, createdName=ms3000000674336927, createdTime=Sat Jan 08 15:45:54 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970477, encodeId=58e99e0477bf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71345456651, createdName=ms3000000193410707, createdTime=Thu Jun 03 02:38:15 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185751, encodeId=4ed9185e5175, content=讲的非常好非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2GMhevabZrvYIDhcYQOadp8uNxP2luzicRh5E0OHqMU9kYxib3dV5Qsd9UASTrkcc9ibiaN90Zwo1Tw/132, createdBy=275f1684782, createdName=wang_shengli, createdTime=Fri Apr 07 10:29:46 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
    2022-01-08 ms3000000674336927

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1182233, encodeId=6343118223372, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90426454317, createdName=ms3000000674336927, createdTime=Sat Jan 08 15:45:54 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970477, encodeId=58e99e0477bf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71345456651, createdName=ms3000000193410707, createdTime=Thu Jun 03 02:38:15 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185751, encodeId=4ed9185e5175, content=讲的非常好非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2GMhevabZrvYIDhcYQOadp8uNxP2luzicRh5E0OHqMU9kYxib3dV5Qsd9UASTrkcc9ibiaN90Zwo1Tw/132, createdBy=275f1684782, createdName=wang_shengli, createdTime=Fri Apr 07 10:29:46 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
    2021-06-03 ms3000000193410707

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1182233, encodeId=6343118223372, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90426454317, createdName=ms3000000674336927, createdTime=Sat Jan 08 15:45:54 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970477, encodeId=58e99e0477bf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71345456651, createdName=ms3000000193410707, createdTime=Thu Jun 03 02:38:15 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185751, encodeId=4ed9185e5175, content=讲的非常好非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo2GMhevabZrvYIDhcYQOadp8uNxP2luzicRh5E0OHqMU9kYxib3dV5Qsd9UASTrkcc9ibiaN90Zwo1Tw/132, createdBy=275f1684782, createdName=wang_shengli, createdTime=Fri Apr 07 10:29:46 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
    2017-04-07 wang_shengli

    讲的非常好非常棒

    0